M. I. Bruce, B. C. Hall, B. W. Skelton, A. H. White
876, [MϪPPh3]ϩ; 841, [MϪClϪPPh3]ϩ; 795, [MϪClϪPPh3Ϫ3Me]ϩ. Elec-
trochemistry (CH2Cl2): E1 ϭ 0.068, E2 ϭ 0.670 V.
Reagents
[RuCl2(Bu2t bpy)(PPh3)2] was obtained by the cited method [11].
Other reagents were commercial products and were used as re-
ceived.
[RuCl{CϵCCPh2(OH)}(PPh3)2(Bu2t bipy)] (6).
A solution of 1
(100 mg, 0.10 mmol) and HCϵCCPh2OH (31 mg, 0.15 mmol) in
CH2Cl2 (15 ml) with TlPF6 (36 mg, 0.10 mmol) was stirred at r.t.
for 6 h. Solvent was removed and a CH2Cl2 extract of the residue
was filtered through cotton wool into cold hexane (50 ml) to give
red-purple [RuCl{CϵCCPh2(OH)}(PPh3)2(Bu2t bipy)] (6) (98 mg,
86 %). A satisfactory elemental analysis was not obtained for this
complex.
[RuCl(CϵCPh)(PPh3)2(Bu2t bpy)] (2). To a solution of 1 (200 mg,
0.21 mmol) and HCϵCPh (31 μl, 0.30 mmol) in CH2Cl2 (15 ml)
was added Tl[PF6] (72 mg, 0.21 mmol) and the resulting solution
was stirred at r.t. for 3 d. The solvent was removed and the residue
extracted with CH2Cl2 and purified on an alumina column. Elution
with acetone/hexane (3:7) gave a red fraction, which was recrys-
tallized from CH2Cl2/hexane to give red microcrystalline
[RuCl(CϵCPh) (PPh3)2(Bu2t bpy)] (2) (121 mg, 57 %). Anal. Calcd
for C62H59ClN2P2Ru (M ϭ 1030): C, 72.25; H, 5.77; N, 2.72;
Found: C, 72.13; H, 5.80; N, 2.68 %.
IR (nujol, cmϪ1): ν(CϵC) 2056. 1H NMR (CDCl3): δ 1.25 (s, 18H, But),
6.37, 8.49 (2 x d, 2H, Hbpy), 6.98Ϫ7.72 (m, 37H, ArH). 13C NMR (CDCl3):
δ 30.61 (s, CMe3), 34.51 (s, CMe3), 89.15 (s, CϵC), 115.62 (s, CϵC), 127.13,
128.02, 128.29, 128.76, 132.14, 134.17 (s, ArH) ppm. ES-MS (MeOH, m/z):
1030, Mϩ; 995, [MϪCl]ϩ; 893, [MϪClϪCϵCPh]ϩ; 733, [MϪClϪPPh3]ϩ.
Electrochemistry (CH2Cl2): E1 ϭ 0.15 V, E2 ϭ 0.36 V.
IR (nujol, cmϪ1): ν(OH) 3400, ν(CϵC) 2059. 1H NMR (CDCl3): δ 1.28 (s,
18H, But), 1.86 (br s, 1H, OH), 6.83, 8.21 (2 x d, 2 x 2H, Hbpy), 6.99Ϫ7.72
(m, 42H, ArH). 13C NMR (CDCl3): δ 30.43 (s, CMe3), 127.07, 127.93, 134.12
(s, ArH) ppm. 31P NMR (CDCl3): δ 23.69 (s, PPh3). ES-MS (MeCN/Na-
OMe, m/z): 1119, [MϪOH]ϩ; 897, [MϪPPh3
ϩ
Na]ϩ; 857,
[MϪPPh3ϪOH]ϩ; 821, [MϪPPh3ϪClϪOH]ϩ; 748, [MϪPPh3ϪPh2OH ϩ
MeCN]ϩ;
708,
[MϪPPh3ϪCϵCCPh2OH
ϩ
MeCN]ϩ;
667,
[MϪPPh3ϪCϵCCPh2OH]ϩ, 631, [MϪPPh3ϪClϪCϵCCPh2OH]ϩ.
Structure determinations
Full spheres of diffraction data were measured at ca. 100 K using
an Oxford Diffraction CCD area-detector instrument. Ntot reflec-
tions were merged to N unique (Rint cited) after ’empirical’/multi-
scan absorption correction (proprietary software), No with F >
4σ(F) being considered ’observed’. All data were measured using
monochromatic Mo-Kα radiation, λ ϭ 0.71073 A. Anisotropic dis-
placement parameter forms were refined for the non-hydrogen
atoms, (x, y, z, Uiso)H being included following a riding model, in
[RuCl(CϵCC6H4NO2)(PPh3)2(Bu2t bpy)] (3). Similarly, 1 (200 mg,
0.21 mmol) and HCϵCC6H4NO2 (31 mg, 0.21 mmol) in CH2Cl2
(15 ml) with Tl[PF6] (72 mg, 0.21 mmol) gave a purple fraction,
which was recrystallized from CH2Cl2/hexane to give purple micro-
crystalline [RuCl(CϵCC6H4NO2)(PPh3)2(Bu2t bpy)] (3) (135 mg,
60 %). Anal. Calcd (C62H58ClN3O2P2Ru): C, 69.23; H, 5.44; N,
3.91; M, 1075; Found: C, 69.30; H, 5.47; N, 4.02 %.
˚
the full matrix least squares refinements on F2. Neutral atom com-
plex scattering factors were used; computation used the XTAL 3.7
[weights: (σ2(F2) ϩ nwF2)Ϫ1] and SHELXL 97 [weights: (σ2(F2) ϩ
(aP)2)Ϫ1 (P ϭ (F2o ϩ 2F2c)/3] program systems [13]. Pertinent results
are given in the Figure (which shows the non-disordered 5 as
exemplary, non-hydrogen atoms having 50 % probability amplitude
displacement envelopes and hydrogen atoms with arbitrary radii of
IR (nujol, cmϪ1): ν(CϵC) 2034. 1H NMR (CDCl3): δ 1.28, 1.36 (s, 18H,
But), 6.20, 8.09, 8.81 (3 x d, 3 x 2H, Hbpy), 6.84Ϫ7.76 (m, 34H, ArH). 13C
NMR (CDCl3): δ 30.60 (s, CMe3), 34.81 (s, CMe3), 82.27 (s, CϵC), 110.71
(s, CϵC), 123.07Ϫ134.16 (m, ArH) ppm. ES-MS (MeOH/NaOMe, m/z):
1098, [M
[MϪCϵCC6H4NO2
[MϪClϪPPh3 ϩ Na]ϩ. Electrochemistry (CH2Cl2): E1 ϭ 0.35 V.
ϩ
Na]ϩ; 1063, [MϪCl
ϩ
Na]ϩ; 1040, [MϪCl]ϩ; 952,
ϩ
Na]ϩ; 894, [MϪCϵCC6H4NO2
Ϫ
Cl]ϩ; 801,
[RuCl(CϵCCO2Me)(PPh3)2(Bu2t bpy)] (4). Similarly,
1
(200 mg,
˚
0.1 A), and in the Tables.
0.21 mmol) and HCϵCCO2Me (25 mg, 0.30 mmol) in CH2Cl2
(15 ml) with Tl[PF6] (72 mg, 0.21 mmol) at r.t. for 16 h gave an
orange fraction, which was recrystallized from CH2Cl2/hexane to
give orange microcrystalline [RuCl(CϵCCO2Me)(PPh3)2(Bu2t bpy)]
(4) (112 mg, 53 %). Anal. Calcd for C58H57ClN2O2P2Ru (M ϭ
1012): C, 68.80; H, 5.67; N, 2.77. Found: C, 68.73; H, 5.72; N,
2.72 %.
Variata. For all specimens (unsolvated), even at 100 K, the data
range was seriously limited.
Compound 5 yielded the only determination unimpeded by serious
disorder; even so, the specimen suffered from a very broad mo-
saicity and yielded inferior residuals.
IR (nujol, cmϪ1): ν(CϵC) 2020, ν(CO 1915. 1H NMR (CDCl3): δ 1.36, 1.43
(s, 18H, But), 2.84 (s, 3H, CO2Me), 6.78, 7.73, 7.97, 8.07 (4 x d, 8H, Hbpy),
7.12Ϫ7.41 (m, 30H, ArH). 13C NMR (CDCl3): δ 30.56 (s, CMe3), 35.19 (s,
CMe3), 48.50 (s, CO2Me), 116.64, 117.07, 117.57, 122.90 (s, bpy), 127.79,
129.61, 133.42 (s, ArH), 154.23 (s, CO2Me). ES-MS (MeOH/NaOMe, m/z):
1035, [M ϩ Na]ϩ; 1012, Mϩ; 977, [MϪCl]ϩ. Electrochemistry (CH2Cl2):
E1 ϭ 0.47, E2 ϭ 0.88 V.
Compound 3: There are two independent (half-)molecules in the
asymmetric unit, both similarly disposed with respect to crystallo-
graphic mirror planes in space group P2/m which contain the bpy
ring planes and the ClRuCϵC-C···CN components. In molecule 1
the mirror plane also contains the CC(H3) components of the bpy
substituents; the phenyl ring and associated nitro group of the
alkyne substituent are disordered over orientations in and normal
to the mirror plane, occupancies of the two components being set
at 0.5 after trial refinement. For molecule 2, two of the phenyl
rings of the PPh3 ligand, and the But substituents were modelled
as disordered over pairs of sites, occupancies 0.5.
[RuCl(CϵCFc)(PPh3)2(Bu2t bipy)] (5). From 1 (100 mg, 0.10 mmol)
and HCϵCFc (31 mg, 0.15 mmol) in CH2Cl2 (15 ml) with Tl[PF6]
(36 mg, 0.10 mmol) at r.t. for 3 d, and purification by column chro-
matography and preparative t.l.c. plates, a red fraction (acetone-
hexane, 2/3) (Rf ϭ 0.6) was recrystallised from CH2Cl2/hexane to
give red microcrystalline [RuCl(CϵCFc)(PPh3)2(Bu2t bipy)] (5)
(48 mg, 42 %). Anal. Calcd for C66H63ClFeN2P2Ru (M ϭ 1138):
C, 69.58; H, 5.58; N, 2.46. Found: C, 69.67; H, 5.61; N, 2.50 %.
Compound 4: There are two independent molecules, devoid of crys-
tallographic symmetry, in the asymmetric unit; both are disordered.
In molecule 1, two of the phenyl rings of one of the PPh3 ligands,
and both But substituents are disordered over pairs of sites, the
disorder seemingly concerted, occupancies refining to 0.615(5) and
complement. Similar disorder is found in molecule 2 except that
only one But substituent was modelled as disordered, disorder oc-
IR (nujol, cmϪ1): ν(CϵC) 2066. 1H NMR (C6D6): δ 1.20 (s, 18H, But), 3.41,
4.04 (2 x m, 2 x 2H, C5H4), 3.57 (s, 5H, Cp), 6.97Ϫ7.79 (m, 36H, ArH). 13
C
NMR (C6D6): δ 25.21 (s, CMe3), 29.03 (s, CMe3), 66.79 (s, C5H4), 67.21 (s,
Cp), 109.37 (s, CϵC), 128.09Ϫ134.71 (m, Ar and ArH). ES-MS (MeOH,
m/z): 1161, [M ϩ Na]ϩ; 1138, Mϩ; 1103, [M-Cl]ϩ; 894, [MϪClϪCϵCFc]ϩ;
1100
© 2008 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Z. Anorg. Allg. Chem. 2008, 1097Ϫ1101